epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Olumiant
    baricitinib

multicheck MultiCheck Results - 0 Interaction

Smiley face Smiley face

Additional Considerations

Smiley face Smiley face baricitinib in Olumiant

FDA Emergency Use Authorization for COVID-19: clinical drug interaction studies not available with other JAK Inhibitors or DMARDs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information